Pershing Square Announces New Position in Valeant Pharmaceuticals International

March 10, 2015 13:55 Korea Standard Time

AMSTERDAM--(Business Wire / Korea Newswire)--Regulatory News:

Pershing Square Holdings, Ltd. (ticker: PSH:NA) announced today a new position in Valeant Pharmaceuticals International, Inc. (ticker: NYSE: VRX) representing approximately 16.9% of the PSH portfolio (based on the closing NAV of PSH and the closing share price of VRX on Friday, 6 March 2015).

Pershing Square Capital Management, L.P., the investment manager for Pershing Square Holdings, Ltd., announced that various funds it manages have purchased 16,473,933 shares of Valeant Pharmaceuticals International, Inc., representing 4.9% of Valeant.

About Pershing Square Holdings, Ltd.

Pershing Square Holdings, Ltd. is a concentrated, research‐intensive, fundamental value investor in the public markets.

Website: http://www.pershingsquareholdings.com

Contact

Pershing Square Holdings, Ltd.

StockWell Communications
Tim Burt
+44 (0)20 7240 2486

This is a news release distributed by Korea Newswire on behalf of this company.